Hospital Regional Universitario de Málaga

Institution (Healthcare)

Homepage ROR

Also Known As

Hospital Regional Universitario de Málaga, Hospital Regional de Málaga

8.2K

Publications

278.4K

Citations

840

Authors

914

Concepts

About

Hospital Regional Universitario de Málaga is a healthcare institution in Málaga, Spain known for medicine, public health, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	38	374	19.3K
2	Engineering	19	39	2.1K
3	Education	3	7	122
4	Language Studies	2	7	117
5	Arts	1	3	69

Hospital Regional Universitario de Málaga

8.2K

Publications

278.4K

Citations

Page 1

	Year	Citations
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial Achim Rittmeyer, Fabrice Barlési, Daniel Waterkamp, The Lancet Non-small-cell Lung CancerMedicineMetronomic TherapyClinical TrialsPathology	2016	4.7K
Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer Thierry André, Kai‐Keen Shiu, Tae Won Kim, New England Journal of Medicine	2020	2.8K
Analysis of shared heritability in common disorders of the brain Verneri Anttila, Brendan Bulik‐Sullivan, Hilary K. Finucane, Science Brain FunctionPsychiatric DisordersGeneticsGenetic EpidemiologyNeuropsychiatry	2018	2K
Immunosuppressive therapy in lupus nephritis: The Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide Frédéric Houssiau, Carlos Vasconcelos, David D’Cruz, Arthritis & Rheumatism	2002	1.1K
World Allergy Organization Anaphylaxis Guidance 2020 Victòria Cardona, Ignacio J. Ansotegui, Motohiro Ebisawa, World Allergy Organization Journal	2020	999
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients Ricard Cervera, Rosa Serrano, Guillermo Pons‐Estel, Annals of the Rheumatic Diseases	2014	941
Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial Mariano Provencio, Ernest Nadal, Amelia Insa, The Lancet Oncology MedicineImmune Checkpoint InhibitorCancer TreatmentOncologyRadiation Oncology	2020	788
The Southampton Consensus Guidelines for Laparoscopic Liver Surgery Mohammad Abu Hilal, Luca Aldrighetti, Ibrahim Dagher, Annals of Surgery	2017	674
The Medical Management of Paediatric Crohn’s Disease: an ECCO-ESPGHAN Guideline Update Patrick F. van Rheenen, Marina Aloi, Amit Assa, Journal of Crohn s and Colitis	2020	648
Complications Associated with Brucella melitensis Infection: A Study of 530 Cases Jordi Colmenero, J.M. Reguera, Francisco Martos, Medicine	1996	631

Page 1